Clinical Trials Logo

Clinical Trial Summary

This study aims to compare subjective image quality and diagnostic accuracy of a photon counting detector computed tomography (PCD-CT) scanner compared with an energy integrating detector (EID)-CT scanner as the reference standard.


Clinical Trial Description

Computed tomography (CT) imaging plays a key role in diagnostic radiology, and is particularly valuable in assessing a myriad of musculoskeletal conditions (e.g. trauma, degenerative disorders, post-surgical follow-up, inflammatory diseases). The vast majority of today's CT scanners are equipped with an energy-integrating detector (EID), which converts energy of incoming X-ray photons in a two-step process into electric signals: First, scintillators generate visible light, which in turn is converted to the electric signal by photodiodes. Recently, photon-counting detector computed tomography (PCD-CT) scanners became commercially available and have been introduced to improve imaging performance through direct transformation of X-ray photons into electron hole pairs upon absorption in a semiconductor layer, generating an electrical signal proportional to the photon energy. Current literature has shown that PCD-CT can offer higher spatial resolution, increased contrast-to-noise ratio, higher dose-efficiency, and inherent multi-spectral imaging capacity. Moreover, the results from cadaver studies suggest that PCD-CT can preserve image quality with reduced radiation dose. However, data on the diagnostic accuracy of PCD-CT compared to EID-CT is currently limited in the field of musculoskeletal radiology. In addition to conventional CT acquisition, multi-spectral CT imaging in patients with gout and after trauma, is used in clinical routine to delineate materials with a specific absorption coefficient: in gout, urate crystals can be visualized, while after trauma, bone marrow edema can be detected. For EID-CT, different techniques for multi-spectral CT imaging are available (e.g. fast kV switching, dual source CT) which are widely used in clinical routine. Multi-spectral imaging is also inherently available for recently introduced PCD-CT. However, data on diagnostic accuracy of multi-spectral PCD-CT is currently lacking. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06281808
Study type Interventional
Source Balgrist University Hospital
Contact Reto Sutter, MD
Phone 0041443861111
Email reto.sutter@balgrist.ch
Status Not yet recruiting
Phase N/A
Start date February 28, 2024
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Completed NCT01415414 - Observational Study of Ultravist in Patients Requiring CECT N/A
Terminated NCT00975299 - Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers Phase 1
Not yet recruiting NCT05036460 - Real-time Sonography in Detecting Inadvertent Esophageal Intubation Among Difficult Intubation Patients N/A
Recruiting NCT05610098 - Gene Expression Profiles in Spinal Tuberculosis.
Completed NCT01009359 - Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers Phase 1
Completed NCT00244140 - Ultravist: Safety and Efficacy in Computed Tomography of Head and Body Phase 3
Completed NCT02980081 - Abdominal Plain X-ray in the Emergency Departement N/A
Completed NCT01205321 - PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers Phase 1
Recruiting NCT05823857 - Effect of an Aquatic Exercise Program in Patients With Chronic Low Back Pain N/A
Recruiting NCT04859634 - Real-time Artificial Intelligence System for Detecting Multiple Ocular Fundus Lesions by Ultra-widefield Fundus Imaging
Completed NCT03125629 - Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals Phase 2
Terminated NCT03167190 - Ultrasound-Assisted Lumbar Puncture N/A
Completed NCT01297088 - PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations. Phase 1
Completed NCT01089998 - PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations Phase 1
Completed NCT00347022 - A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications Phase 4
Completed NCT00876083 - PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination N/A
Completed NCT01411449 - Primovist Post-marketing Surveillance in Japan N/A
Completed NCT01153607 - Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers Phase 1
Completed NCT00709852 - Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging Phase 3
Terminated NCT00659776 - MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation Phase 2